Latest debt-to-equity ratio
Cumberland Pharmaceuticals Debt-to-equity ratio
Direct answer
Cumberland Pharmaceuticals's debt-to-equity ratio is 27.56%.
The verified market snapshot reports 27.56%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked September 17, 2026.
Get free Cumberland Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Debt-to-equity ratio
- 27.56%
Explore related company data
View Cumberland Pharmaceuticals's market capitalizationView Cumberland Pharmaceuticals's price-to-book ratioView Cumberland Pharmaceuticals's return on equityView Cumberland Pharmaceuticals's 52-week price rangeView Cumberland Pharmaceuticals's revenue growthView Cumberland Pharmaceuticals's profit marginView all Cumberland Pharmaceuticals key metricsReturn to Cumberland Pharmaceuticals profile